EVIIVE AG is a startup based in Switzerland.
EVIIVE AG develops blood-based diagnostics that profile extracellular vesicles (EVs) using single-EV multi-omics to discover biomarkers and guide immuno-oncology treatment selection and companion diagnostics.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.